Peripheral Arterial Disease of the LegsReferencesCitationsBurns P, et al. (2003). Management of peripheral
arterial disease in primary care. BMJ, 326(7389):
584–588. White C (2007). Intermittent claudication.
New England Journal of Medicine, 356(12): 1241–1250.
Hirsch AT, et al. (2006). ACC/AHA 2005 Practice
Guidelines for the management of patients with peripheral arterial disease
(lower extremity, renal, mesenteric, and abdominal aortic): A collaborative
report from the American Association for Vascular Surgery/Society for Vascular
Surgery, Society for Cardiovascular Angiography and Interventions, Society for
Vascular Medicine and Biology, Society of Interventional Radiology, and the
ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop
Guidelines for the Management of Patients With Peripheral Arterial Disease):
Endorsed by the American Association of Cardiovascular and Pulmonary
Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular
Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease
Foundation. Circulation, 113(11): e463–e654. Mehler PS, et al. (2003). Intensive blood pressure
control reduces the risk of cardiovascular events in patients with peripheral
arterial disease and type 2 diabetes. Circulation,
107(5): 753–756. Regensteiner JG, Hiatt WR (2002). Current medical
therapies for patients with peripheral arterial disease: A critical review.
American Journal of Medicine, 112(1): 49–57. Mohler ER III, et al., (2003). Cholesterol reduction
with atorvastatin improves walking distance in patients with peripheral
arterial disease. Circulation, 108(12):
1481–1486. Cassar K, Bachoo P (2006). Peripheral arterial
disease, search date December 2005. Online version of Clinical
Evidence (15).
Other Works ConsultedAmerican Heart Association and American College of
Cardiology (2006). AHA/ACC guidelines for secondary prevention for patients
with coronary and other atherosclerotic vascular disease: 2006 update.
Circulation, 113(19): 2363–2372. [Erratum in
Circulation, 113(22): 847.] Hiatt WR (2001). Medical treatment of peripheral
arterial disease and claudication. New England Journal of
Medicine, 344(21): 1608–1621. Husten CG, Thorne SL (2008). Tobacco: Health effects
and control. In RB Wallace, ed., Maxcy-Rosenau-Last Public
Health and Preventive Medicine, 15th ed., pp. 953–998. New York:
McGraw-Hill. Norgren L, et al. (2007). Inter-society consensus for
the management of peripheral arterial disease (TASC II). European Journal of Vascular Surgery, 33 (Suppl 1):
S1–S70.
| |